Drug target identification for neuronal apoptosis through a genome scale screening

Current Medicinal Chemistry

Volumn 17, Issue 26, 2010, Pages 2906-2920

  Tendi, E A ^a   Cunsolo, R ^b   Bellia, D ^b,c   Messina, R L ^b,c   Paratore, S ^b,c   Calissano, P ^d   Cavallaro, S ^b,c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^d EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Apoptosis; Drug; Neuronal; Pharmacogenomics; Programmed cell death; Systems biology; Target

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CEREBELLAR GRANULE NEURON; CEREBELLUM; DNA MICROARRAY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; NERVE CELL; NONHUMAN; RNA EXTRACTION;

APOPTOSIS; DRUG DELIVERY SYSTEMS; HUMANS; MICROARRAY ANALYSIS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; PHARMACOGENETICS;

EID: 77955637983     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710792065081     Document Type: Article

References (118)

1. Oppenheim, R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci., 1991, 14, 453-501.
2. Pettmann, B.; Henderson, C.E. Neuronal cell death. Neuron, 1998, 20, 633-647.
3. Arends, M.J.; Wyllie, A.H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol., 1991, 32, 223-254.
4. Mattson, M. P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid. Redox. Signal., 2006, 8, 1997-2006.
5. Jellinger, K.A. Challenges in neuronal apoptosis. Curr. Alzheimer Res., 2006, 3, 377-391.
6. Rideout, H.J.; Stefanis, L. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol. Cell Neurosci., 2002, 21, 223-238.
7. Porcile, C.; Piccioli, P.; Stanzione, S.; Bajetto, A.; Bonavia, R.; Barbero, S.; Florio, T.; Schettinia, G. Proteasome inhibitors induce cerebellar granule cell death: inhibition of nuclear factor-kB activation. Ann. N. Y. Acad. Sci., 2002, 973, 402-413.
8. Tatton, W.G.; Chalmers-Redman, R.M.; Ju, W.J.; Mammen, M.; Carlile, G.W.; Pong, A.W.; Tatton, N.A. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J. Pharmacol. Exp. Ther., 2002, 301, 753-764.
9. Klettner, A.; Baumgrass, R.; Zhang, Y.; Fischer, G.; Burger, E.; Herdegen, T.; Mielke, K. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Brain Res. Mol. Brain Res., 2001, 97, 21-31.
10. Aoki, T.; Koike, T.; Nakano, T.; Shibahara, K.; Kondo, S.; Kikuchi, H.; Honjo, T. Induction of Bip mRNA upon programmed cell death of differentiated PC12 cells as well as rat sympathetic neurons. J. Biochem., 1997, 121, 122-127.
11. Mills, E.M.; Gunasekar, P.G.; Pavlakovic, G.; Isom, G.E. Cyanide-induced apoptosis and oxidative stress in differentiated PC12 cells. J. Neurochem., 1996, 67, 1039-1046.
12. Villa, P.; Miehe, M.; Sensenbrenner, M.; Pettmann, B. Synthesis of specific proteins in trophic factor-deprived neurons undergoing apoptosis. J. Neurochem., 1994, 62, 1468-1475.
13. Pittman, R.N.; Wang, S.; DiBenedetto, A.J.; Mills, J.C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci., 1993, 13, 3669-3680.
14. Mesner, P. W.; Winters, T.R.; Green, S.H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol., 1992, 119, 1669-1680.
15. D'Mello, S.R.; Galli, C.; Ciotti, T.; Calissano, P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A, 1993, 90, 10989-10993.
16. Galli, C.; Meucci, O.; Scorziello, A.; Werge, T.M.; Calissano, P.; Schettini, G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci., 1995, 15, 1172-1179.
17. Cavallaro, S.; D'Agata, V.; Alessi, E.; Coffa, S.; Alkon, D.L.; Manickam, P.; Ciotti, M.T.; Possenti, R.; Bonini, P.; Marlier, L.; Calissano, P. Gene expression profiles of apoptotic neurons. Genomics, 2004, 84, 485-496.
18. Paratore, S.; Parenti, R.; Torrisi, A.; Copani, A.; Cicirata, F.; Cavallaro, S. Genomic profiling of cortical neurons following exposure to beta-amyloid. Genomics, 2006, 88, 468-479.
19. Gupta, N.; Santhosh, S.R.; Babu, J.P.; Parida, M.M.; Rao, P.V. Chemokine profiling of Japanese encephalitis virus-infected mouse neuroblastoma cells by microarray and real-time RT-PCR: implication in neuropathogenesis. Virus Res., 2010, 147, 107-112.
20. Dasari, V.R.; Veeravalli, K.K.; Tsung, A.J.; Gondi, C.S.; Gujrati, M.; Dinh, D.H.; Rao, J.S. Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury. J. Neurotrauma, 2009, 26, 2057-2069.
21. Recuero, M.; Vicente, M.C.; Martinez-Garcia, A.; Ramos, M.C.; Carmona-Saez, P.; Sastre, I.; Aldudo, J.; Vilella, E.; Frank, A.; Bullido, M.J.; Valdivieso, F. A free radical-generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease. Aging Cell., 2009, 8, 128-139.
22. Kai, Y.; Wang, C.C.; Kishigami, S.; Kazuki, Y.; Abe, S.; Takiguchi, M.; Shirayoshi, Y.; Inoue, T.; Ito, H.; Wakayama, T.; Oshimura, M. Enhanced apoptosis during early neuronal differentiation in mouse ES cells with autosomal imbalance. Cell Res., 2009, 19, 247-258.
23. Ford, G.D.; Ford, B.D.; Steele, E.C., Jr.; Gates, A.; Hood, D.; Matthews, M.A.; Mirza, S.; Macleish, P.R. Analysis of transcriptional profiles and functional clustering of global cerebellar gene expression in PCD3J mice. Biochem. Biophys. Res. Commun., 2008, 377, 556-561.
24. Moran, J.M.; Gonzalez-Polo, R.A.; Ortiz-Ortiz, M.A.; Niso-Santano, M.; Soler, G.; Fuentes, J.M. Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways. J. Toxicol. Environ Health A., 2008, 71, 1457-1467.
25. Jacobs, S.B.; Basak, S.; Murray, J.I.; Pathak, N.; Attardi, L.D. Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ., 2007, 14, 1374-1385.
26. Eve, D.J.; Dennis, J.S.; Citron, B.A., Transcription factor p53 in degenerating spinal cords. Brain Res., 2007, 1150, 174-181.
27. Anantharam, V.; Lehrmann, E.; Kanthasamy, A.; Yang, Y.; Banerjee, P.; Becker, K.G.; Freed, W.J.; Kanthasamy, A.G. Microarray analysis of oxidative stress regulated genes in 2918 mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Neurochem. Int., 2007, 50, 834-847.
28. Khalyfa, A.; Chlon, T.; Qiang, H.; Agarwal, N.; Cooper, N.G. Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Mol. Vis., 2007, 13, 293-308.
29. Koh, C.H.; Peng, Z.F.; Ou, K.; Melendez, A.; Manikandan, J.; Qi, R.Z.; Cheung, N.S. Neuronal apoptosis mediated by inhibition of intracellular cholesterol transport: microarray and proteomics analyses in cultured murine cortical neurons. J. Cell Physiol., 2007, 211, 63-87.
30. Ghoumari, A.M.; Piochon, C.; Tomkiewicz, C.; Eychenne, B.; Levenes, C.; Dusart, I.; Schumacher, M.; Baulieu, E.E. Neuroprotective effect of mifepristone involves neuron depolarization. FASEB J., 2006, 20, 1377-1386.
31. Koh, C.H.; Qi, R.Z.; Qu, D.; Melendez, A.; Manikandan, J.; Bay, B.H.; Duan, W.; Cheung, N.S. U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal., 2006, 18, 1572-1583.
32. Ueno, M.; Katayama, K.; Yamauchi, H.; Nakayama, H.; Doi, K. Cell cycle and cell death regulation of neural progenitor cells in the 5-azacytidine (5AzC)-treated developing fetal brain. Exp. Neurol., 2006, 198, 154-166.
33. Bhansali, S.G.; Brazeau, D.A.; Sonee, M.; Mukherjee, S.K. Nicotinamide prevents apoptosis in human cortical neuronal cells. Toxicol. Mech. Methods., 2006, 16, 173-180.
34. Jayanthi, S.; Deng, X.; Ladenheim, B.; McCoy, M.T.; Cluster, A.; Cai, N.S.; Cadet, J.L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 868-873.
35. Desagher, S.; Severac, D.; Lipkin, A.; Bernis, C.; Ritchie, W.; Le Digarcher, A.; Journot, L. Genes regulated in neurons undergoing transcription-dependent apoptosis belong to signaling pathways rather than the apoptotic machinery. J. Biol. Chem., 2005, 280, 5693-5702.
36. Miller, R.M.; Callahan, L.M.; Casaceli, C.; Chen, L.; Kiser, G.L.; Chui, B.; Kaysser-Kranich, T.M.; Sendera, T.J.; Palaniappan, C.; Federoff, H.J. Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J. Neurosci., 2004, 24, 7445-7454.
37. Eng, S.R.; Lanier, J.; Fedtsova, N.; Turner, E.E. Coordinated regulation of gene expression by Brn3a in developing sensory ganglia. Development., 2004, 131, 3859-3870.
38. Reimertz, C.; Kogel, D.; Rami, A.; Chittenden, T.; Prehn, J.H. Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J. Cell Biol., 2003, 162, 587-597.
39. Hu, J.; Fink, D.; Mata, M. Microarray analysis suggests the involvement of proteasomes, lysosomes, and matrix metalloproteinases in the response of motor neurons to root avulsion. Eur. J. Neurosci., 2002, 16, 1409-1416.
40. Fortin, A.; Cregan, S.P.; MacLaurin, J.G.; Kushwaha, N.; Hickman, E.S.; Thompson, C.S.; Hakim, A.; Albert, P.R.; Cecconi, F.; Helin, K.; Park, D.S.; Slack, R.S. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J. Cell Biol., 2001, 155, 207-216.
41. Contestabile, A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum, 2002, 1, 41-55.
42. Wood, K.A.; Dipasquale, B.; Youle, R.J. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron., 1993, 11, 621-632.
43. Tanaka, M.; Marunouchi, T. Immunohistochemical analysis of developmental stage of external granular layer neurons which undergo apoptosis in postnatal rat cerebellum. Neurosci. Lett., 1998, 242, 85-88.
44. Cavallaro, S.; Copani, A.; D'Agata, V.; Musco, S.; Petralia, S.; Ventra, C.; Stivala, F.; Travali, S.; Canonico, P.L. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol. Pharmacol., 1996, 50, 60-66.
45. Campard, P.K.; Crochemore, C.; Rene, F.; Monnier, D.; Koch, B.; Loeffler, J.P. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol., 1997, 16, 323-333.
46. Dejda, A.; Jolivel, V.; Bourgault, S.; Seaborn, T.; Fournier, A.; Vaudry, H.; Vaudry, D. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J. Mol. Neurosci., 2008, 36, 26-37.
47. Dohi, K.; Mizushima, H.; Nakajo, S.; Ohtaki, H.; Matsunaga, S.; Aruga, T.; Shioda, S. Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways. Regul. Pept., 2002, 109, 83-88.
48. Falluel-Morel, A.; Aubert, N.; Vaudry, D.; Basille, M.; Fontaine, M.; Fournier, A.; Vaudry, H.; Gonzalez, B.J. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem., 2004, 91, 1231-1243.
49. Brewster, J.L.; Linseman, D.A.; Bouchard, R.J.; Loucks, F.A.; Precht, T.A.; Esch, E.A.; Heidenreich, K.A. Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 beta and a caspase-9-dependent apoptosis in cerebellar granule neurons. Mol. Cell Neurosci., 2006, 32, 242-253.
50. Canu, N.; Tufi, R.; Serafino, A.L.; Amadoro, G.; Ciotti, M.T.; Calissano, P. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells. J. Neurochem., 2005, 92, 1228-1242.
51. Chin, P.C.; Majdzadeh, N.; D'Mello, S.R. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res. Mol. Brain Res., 2005, 137, 193-201.
52. D'Mello, S.R.; Borodezt, K.; Soltoff, S.P., Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3- kinase in IGF-1 signaling. J. Neurosci., 1997, 17, 1548-1560.
53. Kenchappa, P.; Yadav, A.; Singh, G.; Nandana, S.; Banerjee, K. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. J. Neurosci. Res., 2004, 76, 466-474.
54. Koulich, E.; Nguyen, T.; Johnson, K.; Giardina, C.; D'Mello, S. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival. J. Neurochem., 2001, 76, 1188-1198.
55. Linseman, D.A.; Phelps, R.A.; Bouchard, R.J.; Le, S.S.; Laessig, T.A.; McClure, M.L.; Heidenreich, K.A. Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci., 2002, 22, 9287-9297.
56. Zhong, J.; Deng, J.; Huang, S.; Yang, X.; Lee, W.H. High K+ and IGF-1 protect cerebellar granule neurons via distinct signaling pathways. J. Neurosci. Res., 2004, 75, 794-806.
57. Subramaniam, S.; Shahani, N.; Strelau, J.; Laliberte, C.; Brandt, R.; Kaplan, D.; Unsicker, K. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J. Neurosci., 2005, 25, 2838-2852.
58. Ravni, A.; Eiden, L.E.; Vaudry, H.; Gonzalez, B.J.; Vaudry, D. Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J. Neurochem., 2006, 98, 1229-1241.
59. Aubert, N.; Falluel-Morel, A.; Vaudry, D.; Xifro, X.; Rodriguez-Alvarez, J.; Fisch, C.; de Jouffrey, S.; Lebigot, J.F.; Fournier, A.; Vaudry, H.; Gonzalez, B.J. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. J. Neurochem., 2006, 99, 1237-1250.
60. Saitoh, T.; Tanaka, S.; Koike, T. Rapid induction and Ca(2+) influx-mediated suppression of vitamin D3 up- regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis. J. Neurochem., 2001, 78, 1267-1276.
61. Chung, H.; Seo, S.; Moon, M.; Park, S. IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4. J. Endocrinol., 2007, 194, 77-85.
62. Cavallaro, S.; Calissano, P. A genomic approach to investigate neuronal apoptosis. Curr. Alzheimer Res., 2006, 3, 285-296.
63. Cavallaro, S. Neuronal apoptosis revealed by genomic analysis: integrating gene expression profiles with functional information. Neuroinformatics, 2007, 5, 115-126.
64. Brown, J.C.; Pederson, R.A.; Jorpes, E.; Mutt, V. Preparation of highly active enterogastrone. Can.J. Physiol. Pharmacol., 1969, 47, 113-114.
65. Hauner, H.; Glatting, G.; Kaminska, D.; Pfeiffer, E.F. Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann. Nutr. Metab, 1988, 32, 282-288.
66. Kogire, M.; Inoue, K.; Sumi, S.; Doi, R.; Yun, M.; Kaji, H.; Tobe, T. Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs. Dig. Dis. Sci., 37, 1666-1670.
67. Bollag, R.J.; Zhong, Q.; Phillips, P.; Min, L.; Zhong, L.; Cameron, R.; Mulloy, A.L.; Rasmussen, H.; Qin, F.; Ding, K.H.; Isales, C.M. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology, 2000, 141, 1228-1235.
68. Drucker, D.J. The biology of incretin hormones. Cell Metab., 2006, 3, 153-165.
69. Hansotia, T.; Drucker, D.J. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul. Pept., 2005, 128, 125-134.
70. Holst, J.J. On the physiology of GIP and GLP-1. Horm. Metab. Res., 2004, 36, 747-754.
71. Brubaker, P.L.; Drucker, D.J. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels, 2002, 8, 179-188.
72. Gault, V.A.; Harriott, P.; Flatt, P.R.; O'Harte, F.P. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide. Biosci. Rep., 2002, 22, 523-528.
73. Yamada, Y.; Hayami, T.; Nakamura, K.; Kaisaki, P.J.; Someya, Y.; Wang, C.Z.; Seino, S.; Seino, Y. Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics, 1995, 29, 773-776.
74. Volz, A.; Goke, R.; Lankat-Buttgereit, B.; Fehmann, H.C.; Bode, H.P.; Goke, B. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. FEBS Lett., 1995, 373, 23-29.
75. Wheeler, M.B.; Gelling, R.W.; McIntosh, C.H.; Georgiou, J.; Brown, J.C.; Pederson, R.A. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology, 1995, 136, 4629-4639.
76. Gremlich, S.; Porret, A.; Hani, E.H.; Cherif, D.; Vionnet, N.; Froguel, P.; Thorens, B. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes, 1995, 44, 1202-1208.
77. Kaplan, A.M.; Vigna, S.R. Gastric inhibitory polypeptide (GIP) binding sites in rat brain. Peptides, 1994, 15, 297-302.
78. Yasuda, K.; Inagaki, N.; Yamada, Y.; Kubota, A.; Seino, S.; Seino, Y. Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties. Biochem. Biophys. Res. Commun., 1994, 205,1556-1562.
79. Usdin, T.B.; Mezey, E.; Button, D.C.; Brownstein, M.J.; Bonner, T.I. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology, 133, 2861-2870.
80. Kim, S.J.; Winter, K.; Nian, C.; Tsuneoka, M.; Koda, Y.; McIntosh, C.H. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J. Biol. Chem., 2005, 280, 22297-22307.
81. Wideman, R.D.; Kieffer, T.J. Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fate. Horm. Metab Res., 2004, 36, 782-786.
82. Trumper, A.; Trumper, K.; Horsch, D. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J. Endocrinol., 2002, 174, 233-246.
83. Nyberg, J.; Anderson, M.F.; Meister, B.; Alborn, A.M.; Strom, A.K.; Brederlau, A.; Illerskog, A.C.; Nilsson, O.; Kieffer, T.J.; Hietala, M.A.; Ricksten, A.; Eriksson, P.S. Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. J. Neurosci., 2005, 25, 1816-1825.
84. Gault, V.A.; Holscher, C. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. J. Neurophysiol., 2008, 99, 1590-1595.
85. Buhren, B.A.; Gasis, M.; Thorens, B.; Muller, H.W.; Bosse, F. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth. J. Neurosci. Res., 2009, 87, 1858-1870.
86. Barrett, G.L. The p75 neurotrophin receptor and neuronal apoptosis. Prog. Neurobiol., 2000, 61, 205-229.
87. Altman, R.B.; Raychaudhuri, S. Whole-genome expression analysis: challenges beyond clustering. Curr. Opin. Struct. Biol., 11, 340-347.
88. Banerjee, N.; Zhang, M.Q. Functional genomics as applied to mapping transcription regulatory networks. Curr. Opin. Microbiol., 5, 313-317.
89. Bicciato, S., Artificial neural network technologies to identify biomarkers for therapeutic intervention. Curr. Opin. Mol. Ther., 2004, 6, 616-623.
90. Fischer, H. P. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol. Annu. Rev., 2005, 11, 1-68.
91. Kanehisa, M.; Goto, S.; Kawashima, S.; Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res., 2002, 30, 42-46.
92. Savoie, C.J.; Aburatani, S.; Watanabe, S.; Eguchi, Y.; Muta, S.; Imoto, S.; Miyano, S.; Kuhara, S.; Tashiro, K. Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected genes and gene regulation cascades. DNA Res., 2003, 10, 19-25.
93. Bender, A.; Young, D.W.; Jenkins, J.L.; Serrano, M.; Mikhailov, D.; Clemons, P.A.; Davies, J.W. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint. Comb. Chem. High Throughput. Screen., 2007, 10, 719-731.
94. Schrattenholz, A.; Soskic, V. What does systems biology mean for drug development? Curr. Med. Chem., 2008, 15, 1520-1528.
95. Rual, J.F.; Venkatesan, K.; Hao, T.; Hirozane-Kishikawa, T.; Dricot, A.; Li, N.; Berriz, G.F.; Gibbons, F.D.; Dreze, M.; Ayivi-Guedehoussou, N.; Klitgord, N.; Simon, C.; Boxem, M.; Milstein, S.; Rosenberg, J.; Goldberg, D.S.; Zhang, L.V.; Wong, S.L.; Franklin, G.; Li, S.; Albala, J.S.; Lim, J.; Fraughton, C.; Llamosas, P.; Cevik, S.; Bex, C.; Lamesch, P.; Sikorski, R.S.; Vandenhaute, J.; Zoghbi, H.Y.; Smolyar, A.; Bosak, S.; Sequerra, R.; Doucette-Stamm, L.; Cusick, M.E.; Hill, D.E.; Roth, F.P.; Vidal, M. Towards a proteome-scale map of the human protein-protein interaction network. Nature, 2005, 437, 1173-1178.
96. Stelzl, U.; Worm, U.; Lalowski, M.; Haenig, C.; Brembeck, F.H.; Goehler, H.; Stroedicke, M.; Zenkner, M.; Schoenherr, A.; Koeppen, S.; Timm, J.; Mintzlaff, S.; Abraham, C.; Bock, N.; Kietzmann, S.; Goedde, A.; Toksoz, E.; Droege, A.; Krobitsch, S.; Korn, B.; Birchmeier, W.; Lehrach, H.; Wanker, E.E. A human protein-protein interaction network: a resource for annotating the proteome. Cell, 2005, 122, 957-968.
97. Lehne, B.; Schlitt, T. Protein-protein interaction databases: keeping up with growing interactomes. Hum. Genom., 2009, 3, 291-297.
98. Nikolsky, Y.; Ekins, S.; Nikolskaya, T.; Bugrim, A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett., 2005, 158, 20-29.
99. Edgar, R.; Domrachev, M.; Lash, A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 2002, 30, 207-210.
100. Parkinson, H.; Kapushesky, M.; Kolesnikov, N.; Rustici, G.; Shojatalab, M.; Abeygunawardena, N.; Berube, H.; Dylag, M.; Emam, I.; Farne, A.; Holloway, E.; Lukk, M.; Malone, J.; Mani, R.; Pilicheva, E.; Rayner, T.F.; Rezwan, F.; Sharma, A.; Williams, E.; Bradley, X.Z.; Adamusiak, T.; Brandizi, M.; Burdett, T.; Coulson, R.; Krestyaninova, M.; Kurnosov, P.; Maguire, E.; Neogi, S.G.; Rocca-Serra, P.; Sansone, S.A.; Sklyar, N.; Zhao, M.; Sarkans, U.; Brazma, A. Array Express update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res., 2009, 37, D868-D872.
101. Wishart, D.S.; Knox, C.; Guo, A.C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res., 2006, 34, D668-D672.
102. Wishart, D.S.; Knox, C.; Guo, A.C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 2008, 36, D901-D906.
103. Zhu, F.; Han, B.; Kumar, P.; Liu, X.; Ma, X.; Wei, X.; Huang, L.; Guo, Y.; Han, L.; Zheng, C.; Chen, Y. Update of TTD: Therapeutic Target Database. Nucleic Acids Res., 2010, 38, D787-D791.
104. Gong, L.; Owen, R.P.; Gor, W.; Altman, R.B.; Klein, T.E. PharmGKB: an integrated resource of pharmacogenomic data and knowledge. Curr. Protoc. Bioinformatics., 2008, Chp. 14, Unit14.
105. Kuhn, M.; Szklarczyk, D.; Franceschini, A.; Campillos, M.; von Mering, C.; Jensen, L.J.; Beyer, A.; Bork, P. STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res., 2010, 38, D552-D556.
106. Gunther, S.; Kuhn, M.; Dunkel, M.; Campillos, M.; Senger, C.; Petsalaki, E.; Ahmed, J.; Urdiales, E.G.; Gewiess, A.; Jensen, L.J.; Schneider, R.; Skoblo, R.; Russell, R.B.; Bourne, P.E.; Bork, P.; Preissner, R. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res., 2008, 36, D919-D922.
107. Kanehisa, M.; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 2000, 28, 27-30.
108. Kanehisa, M.; Goto, S.; Hattori, M.; Aoki-Kinoshita, K.F.; Itoh, M.; Kawashima, S.; Katayama, T.; Araki, M.; Hirakawa, M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 2006, 34, D354-D357.
109. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 2010, 38, D355-D360.
110. Kang, C.J.; Chen, Y.J.; Liao, C.T.; Wang, H.M.; Chang, J.T.; Lin, C.Y.; Lee, L.Y.; Wang, T.H.; Yen, T.C.; Shen, C.R.; Chen, I.H.; Chiu, C.C.; Cheng, A.J. Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett., 2009, 284, 131-140.
111. Fuchshofer, R.; Stephan, D.A.; Russell, P.; Tamm, E.R. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Exp. Eye Res., 2009, 88, 1020-1032.
112. Krishnan, J.; Chen, J.; Shin, K.J.; Hwang, J.I.; Han, S.U.; Lee, G.; Choi, S. Gene expression profiling of light-induced retinal degeneration in phototransduction gene knockout mice. Exp. Mol. Med., 2008, 40, 495-504.
113. Tanaka, T.; Oka, T.; Shimada, Y.; Umemoto, N.; Kuroyanagi, J.; Sakamoto, C.; Zang, L.; Wang, Z.; Nishimura, Y. Pharmaco-genomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models. J. Pharmacol. Sci., 2008, 107, 8-14.
114. Liu, Y.T.; Shang, D.; Akatsuka, S.; Ohara, H.; Dutta, K.K.; Mizushima, K.; Naito, Y.; Yoshikawa, T.; Izumiya, M.; Abe, K.; Nakagama, H.; Noguchi, N.; Toyokuni, S. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway. Am. J. Pathol., 2007, 171, 1978-1988.
115. Hunsberger, J.G.; Newton, S.S.; Bennett, A.H.; Duman, C.H.; Russell, D.S.; Salton, S.R.; Duman, R.S. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med., 2007, 13, 1476-1482.
116. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol., 2008, 4, 682-690.
117. Volonte, C.; Ciotti, M.T.; Battistini, L. Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry, 1994, 17, 274-276.
118. Lederer, C. W.; Torrisi, A.; Pantelidou, M.; Santama, N.; Cavallaro, S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genom., 2007, 8, 26.